SOPHiA GENETICS SA (SOPH) Misses Q2 EPS by 4c

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.33), $0.04 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $15.1 million versus the consensus estimate of $15.24 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c
• RH (RH) Tops Q1 EPS by 12c